ARS Pharmaceuticals Inc.

NASDAQ: SPRY · Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.65
0.83%
After-hours: Aug 15, 2025, 07:32 PM EDT

ARS Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
50.82M 70.97M 210.52M 60.06M
Short-Term Investments
263.2M 157.39M 63.86M n/a
Long-Term Investments
n/a n/a n/a 64.78M
Other Long-Term Assets
8.11M 21K 2.96M -64.76M
Receivables
9.16M 795K 1.01M 1K
Inventory
5.21M n/a n/a n/a
Other Current Assets
1.23M 163K n/a n/a
Total Current Assets
334.3M 231.73M 277.7M 60.73M
Property-Plant & Equipment
1.07M 824K 774K 693K
Goodwill & Intangibles
7.68M 617K n/a n/a
Total Long-Term Assets
16.86M 1.46M 3.73M 716K
Total Assets
351.15M 233.19M 281.44M 61.45M
Account Payables
9.87M 759K 1.66M 1.79M
Deferred Revenue
557K n/a 283K 1.46M
Short-Term Debt
n/a 237K 230K 3.48M
Other Current Liabilities
2.29M 843K 2.6M 660K
Total Current Liabilities
23.44M 2.39M 5.44M 8.19M
Long-Term Debt
n/a n/a n/a 4.93M
Other Long-Term Liabilities
69.38M n/a 2.85M 76.12M
Total Long-Term Liabilities
70.92M 37K 3.1M 84.53M
Total Liabilities
94.36M 2.43M 8.55M 92.72M
Total Debt
42K 274K 481K 9.03M
Common Stock
10K 10K 9K 3K
Retained Earnings
-123.31M -131.3M -76.94M -42.26M
Comprehensive Income
220K 49K 407K n/a
Shareholders Equity
256.8M 230.76M 272.89M 44.77M
Total Investments
263.2M 157.39M 63.86M 64.78M